Neuronal specific enolase 2 (ENO2) is also known as γ-enolase. It is present in the cytoplasm of neuroendocrine cells.
Immunogène
brain NSE from human.
Actions biochimiques/physiologiques
Neuronal specific enolase 2 (ENO2) has been studied as a biomarker in the progression of multiple sclerosis. It converts 2-phosphoglycerate into phosphoenolpyruvate.
Forme physique
Prediluted in 20 mM HEPES, containing 135 mM NaCI, 1% BSA, and 0.09% sodium azide.
Clause de non-responsabilité
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Vous ne trouvez pas le bon produit ?
Essayez notre Outil de sélection de produits.
Code de la classe de stockage
10 - Combustible liquids
Classe de danger pour l'eau (WGK)
WGK 3
Point d'éclair (°F)
Not applicable
Point d'éclair (°C)
Not applicable
Faites votre choix parmi les versions les plus récentes :
Journal of the neurological sciences, 350(1-2), 46-50 (2015-02-18)
Previous studies suggested that serum neuron specific enolase (NSE) may be a biomarker associated with progression in MS. We measured serum NSE levels in 385 patients with multiple sclerosis (MS) (264 with relapsing-remitting (RR) MS, 86 with secondary progressive (SP)
To integrate and broadcast neural information, local microcircuits and global macrocircuits interact within certain specific nuclei of the central nervous system. The structural and functional architecture of this interaction was determined for the caudal nucleus of the tractus solitarius (NTS)
To explore the relationship between serum neuron-specific enolase (NSE) levels and diabetic neuropathy. Type 1 or 2 diabetic and healthy control subjects (n = 568) were randomly enrolled in a cross-sectional study. Diabetic neuropathy status was documented by the presence
Stem cell-based therapy has been evaluated in many different clinical trials for various diseases. This capability was applied in various neurodegenerative diseases, such as multiple sclerosis, which is characterized by demyelination, axonal injury, and neuronal loss. Dental pulp stem cells
Questions
Reviews
★★★★★ No rating value
Active Filters
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
